The identity of public health in COVID-19 times.


Journal

Acta bio-medica : Atenei Parmensis
ISSN: 2531-6745
Titre abrégé: Acta Biomed
Pays: Italy
ID NLM: 101295064

Informations de publication

Date de publication:
20 07 2020
Historique:
received: 10 07 2020
accepted: 10 07 2020
entrez: 24 7 2020
pubmed: 24 7 2020
medline: 13 8 2020
Statut: epublish

Résumé

The COVID-19 hit the world with devastating clinical, economic and social burden.  If any constructive element arises from this tragedy, it is a greater awareness of the key role of public health, which will also be instrumental in the way out of the crisis. Defined in broader terms as the science of protecting the safety and improving the health of communities through education, policy making and research for disease and injury prevention, public health action has guided COVID-19 surveillance and monitoring, the adoption of containment and mitigation measures, has informed the management and organization of  healthcare delivery in emergency and has fuelled health communication and education to the general population. [...].

Identifiants

pubmed: 32701910
doi: 10.23750/abm.v91i9-S.10200
pmc: PMC8023088
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

5-6

Références

Acta Biomed. 2020 Jul 20;91(9-S):34-39
pubmed: 32701915
Acta Biomed. 2020 Jul 20;91(9-S):87-89
pubmed: 32701921
Acta Biomed. 2020 Jul 20;91(9-S):40-49
pubmed: 32701916
Acta Biomed. 2020 Jul 20;91(9-S):90-91
pubmed: 32701922
Acta Biomed. 2020 Jul 20;91(9-S):50-60
pubmed: 32701917
Acta Biomed. 2020 May 11;91(2):11-12
pubmed: 32420918
Acta Biomed. 2020 Jul 20;91(9-S):76-78
pubmed: 32701919
JAMA. 2020 May 12;323(18):1775-1776
pubmed: 32203977
Acta Biomed. 2020 Jul 20;91(9-S):61-75
pubmed: 32701918
Immunotherapy. 2020 Feb;12(2):105-110
pubmed: 32046555
Acta Biomed. 2020 Apr 10;91(3-S):175-179
pubmed: 32275287
Lancet. 2020 Apr 11;395(10231):1225-1228
pubmed: 32178769
Acta Biomed. 2020 Jul 20;91(9-S):95-96
pubmed: 32701924
Lancet Public Health. 2020 Jun;5(6):e310
pubmed: 32339478
Acta Biomed. 2020 Jul 20;91(9-S):29-33
pubmed: 32701914
Acta Biomed. 2020 Jul 20;91(9-S):79-86
pubmed: 32701920
Acta Biomed. 2020 Jul 20;91(9-S):97-98
pubmed: 32701925
Acta Biomed. 2020 Jul 20;91(9-S):22-28
pubmed: 32701913
Acta Biomed. 2020 Jul 20;91(9-S):7-18
pubmed: 32701911
Acta Biomed. 2020 May 11;91(2):23-30
pubmed: 32420920
Acta Biomed. 2020 Jul 20;91(9-S):19-21
pubmed: 32701912
Acta Biomed. 2020 Jul 20;91(9-S):92-94
pubmed: 32701923

Auteurs

Anna Odone (A)

Editor, Acta Biomedica. odone.anna@hsr.it.

Marco Vitale (M)

Editor, Acta Biomedica. marco.vitale@unipr.it.

Carlo Signorelli (C)

Editor, Acta Biomedica. signorelli.carlo@hsr.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH